This study reveals that R175H and R175G variants in ovarian cancer differ in partners and pathways driving platinum resistance - with CHD1–IL7R emerging as mutation-specific therapeutic targets.
#OvarianCancer
www.nature.com/articles/s41...
This study reveals that R175H and R175G variants in ovarian cancer differ in partners and pathways driving platinum resistance - with CHD1–IL7R emerging as mutation-specific therapeutic targets.
#OvarianCancer
www.nature.com/articles/s41...
Inhibiting PDK1 enhances the effect of APR-246, pointing to a promising combo therapy for TP53-mutant tumors.
#p53 #CancerMetabolism
onlinelibrary.wiley.com/doi/10.1111/...
Inhibiting PDK1 enhances the effect of APR-246, pointing to a promising combo therapy for TP53-mutant tumors.
#p53 #CancerMetabolism
onlinelibrary.wiley.com/doi/10.1111/...
🧬 Strong overall concordance, but a small group shows WT p53 staining despite TP53 mutations - key for diagnosis & treatment.
#p53 #oncology #mutations #diagnosis
🔗 doi.org/10.1111/his....
🧬 Strong overall concordance, but a small group shows WT p53 staining despite TP53 mutations - key for diagnosis & treatment.
#p53 #oncology #mutations #diagnosis
🔗 doi.org/10.1111/his....
If you’re interested in how mutant p53 rewires mitochondrial metabolism to shape tumor adaptation and chemoresistance, take a look 👇
doi.org/10.1016/j.bb...
#p53 #Mitochondria #ColorectalCancer #Oxaliplatin #Metabolism #CancerResearch
If you’re interested in how mutant p53 rewires mitochondrial metabolism to shape tumor adaptation and chemoresistance, take a look 👇
doi.org/10.1016/j.bb...
#p53 #Mitochondria #ColorectalCancer #Oxaliplatin #Metabolism #CancerResearch